CN104114694A - 用于体外扩增造血干细胞和祖细胞的方法 - Google Patents
用于体外扩增造血干细胞和祖细胞的方法 Download PDFInfo
- Publication number
- CN104114694A CN104114694A CN201280052478.8A CN201280052478A CN104114694A CN 104114694 A CN104114694 A CN 104114694A CN 201280052478 A CN201280052478 A CN 201280052478A CN 104114694 A CN104114694 A CN 104114694A
- Authority
- CN
- China
- Prior art keywords
- cell
- hpc
- hsc
- ficolin
- colony
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/59—Lectins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (35)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011903899 | 2011-09-22 | ||
AU2011903899A AU2011903899A0 (en) | 2011-09-22 | Cell culture & expansion | |
PCT/AU2012/001135 WO2013040644A1 (en) | 2011-09-22 | 2012-09-21 | Method for the ex vivo expansion of hematopoietic stem and progenitor cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104114694A true CN104114694A (zh) | 2014-10-22 |
Family
ID=47913674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280052478.8A Pending CN104114694A (zh) | 2011-09-22 | 2012-09-21 | 用于体外扩增造血干细胞和祖细胞的方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9518250B2 (zh) |
EP (1) | EP2748309A4 (zh) |
JP (1) | JP6112462B2 (zh) |
KR (1) | KR20140063861A (zh) |
CN (1) | CN104114694A (zh) |
AU (1) | AU2012313347A1 (zh) |
CA (1) | CA2885665A1 (zh) |
IL (1) | IL231668A0 (zh) |
SG (1) | SG11201400851PA (zh) |
WO (1) | WO2013040644A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110093313A (zh) * | 2018-01-29 | 2019-08-06 | 华南生物医药研究院 | 促进造血干/祖细胞分化为红系细胞的诱导培养基及应用 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016178914A1 (en) * | 2015-05-01 | 2016-11-10 | Cesca Therapeutics, Inc. | Intramuscular adaminstration of autologous bone marrw for treatment |
US10669528B2 (en) * | 2015-06-25 | 2020-06-02 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
CA2991817A1 (en) * | 2015-08-05 | 2017-02-09 | Konstantinos KOKKALIARIS | Use of dermatopontin for maintaining hematopoietic stem and/or progenitor cells in culture |
US20200392533A1 (en) * | 2017-04-11 | 2020-12-17 | President And Fellows Of Harvard College | In vivo gene editing of blood progenitors |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020132017A1 (en) * | 1996-12-09 | 2002-09-19 | Moore Jeffrey G. | Composition and method for preserving progenitor cells |
WO2004089394A2 (en) * | 2003-04-09 | 2004-10-21 | Natimmune A/S | Treatment of severe acute respiratory syndrome (sars) |
CN1557947A (zh) * | 2004-02-11 | 2004-12-29 | 上海伯瑞生物技术发展有限公司 | 一种造血细胞灌注培养方法和装置 |
WO2005007799A2 (en) * | 2003-07-17 | 2005-01-27 | Gamida-Cell Ltd. | Methods for ex-vivo expanding stem/progenitor cells |
WO2005007073A2 (en) * | 2003-07-17 | 2005-01-27 | Gamida-Cell Ltd. | Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
WO2006045064A2 (en) * | 2004-10-20 | 2006-04-27 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
WO2007066352A1 (en) * | 2005-12-06 | 2007-06-14 | Department Of Biotechnology | A method for preservation of human hematopoietic stem or progenitor cells |
WO2008149129A1 (en) * | 2007-06-08 | 2008-12-11 | Nova Thera Limited | Cell expansion |
CN101508975A (zh) * | 2009-03-26 | 2009-08-19 | 大连理工大学 | 一种低氧条件下微囊化成骨细胞支持和调控造血干/祖细胞体外扩增的方法 |
WO2010142295A1 (en) * | 2009-06-10 | 2010-12-16 | Rigshospitalet | Ficolin-3 assay |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008237136A (ja) * | 2007-03-28 | 2008-10-09 | Foundation For Biomedical Research & Innovation | ヒト造血細胞の培養方法 |
US20120169643A1 (en) | 2009-09-09 | 2012-07-05 | Sharp Kabushiki Kaisha | Gesture determination device and method of same |
EP2476752A4 (en) * | 2009-09-11 | 2013-04-03 | Takara Bio Inc | PROCESS FOR THE PRODUCTION OF NATURAL KILLER CELLS |
-
2012
- 2012-09-21 EP EP12832834.1A patent/EP2748309A4/en not_active Withdrawn
- 2012-09-21 SG SG11201400851PA patent/SG11201400851PA/en unknown
- 2012-09-21 KR KR1020147010617A patent/KR20140063861A/ko not_active Application Discontinuation
- 2012-09-21 WO PCT/AU2012/001135 patent/WO2013040644A1/en active Application Filing
- 2012-09-21 CN CN201280052478.8A patent/CN104114694A/zh active Pending
- 2012-09-21 CA CA2885665A patent/CA2885665A1/en active Pending
- 2012-09-21 JP JP2014531047A patent/JP6112462B2/ja not_active Expired - Fee Related
- 2012-09-21 US US14/346,160 patent/US9518250B2/en not_active Expired - Fee Related
- 2012-09-21 AU AU2012313347A patent/AU2012313347A1/en not_active Abandoned
-
2014
- 2014-03-23 IL IL231668A patent/IL231668A0/en unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020132017A1 (en) * | 1996-12-09 | 2002-09-19 | Moore Jeffrey G. | Composition and method for preserving progenitor cells |
WO2004089394A2 (en) * | 2003-04-09 | 2004-10-21 | Natimmune A/S | Treatment of severe acute respiratory syndrome (sars) |
WO2005007799A2 (en) * | 2003-07-17 | 2005-01-27 | Gamida-Cell Ltd. | Methods for ex-vivo expanding stem/progenitor cells |
WO2005007073A2 (en) * | 2003-07-17 | 2005-01-27 | Gamida-Cell Ltd. | Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
CN1557947A (zh) * | 2004-02-11 | 2004-12-29 | 上海伯瑞生物技术发展有限公司 | 一种造血细胞灌注培养方法和装置 |
WO2006045064A2 (en) * | 2004-10-20 | 2006-04-27 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
WO2007066352A1 (en) * | 2005-12-06 | 2007-06-14 | Department Of Biotechnology | A method for preservation of human hematopoietic stem or progenitor cells |
WO2008149129A1 (en) * | 2007-06-08 | 2008-12-11 | Nova Thera Limited | Cell expansion |
CN101508975A (zh) * | 2009-03-26 | 2009-08-19 | 大连理工大学 | 一种低氧条件下微囊化成骨细胞支持和调控造血干/祖细胞体外扩增的方法 |
WO2010142295A1 (en) * | 2009-06-10 | 2010-12-16 | Rigshospitalet | Ficolin-3 assay |
Non-Patent Citations (2)
Title |
---|
GABRIELLA COLUCCI ET AL.: "cDNA cloning of FRIL, a lectin from Dolichos lablab, that preserves hematopoietic progenitors in suspension culture", 《PROC. NATL. ACAD. SCI.》 * |
陈勰 等: "纤维蛋白胶凝素-3研究进展", 《中国临床保健杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110093313A (zh) * | 2018-01-29 | 2019-08-06 | 华南生物医药研究院 | 促进造血干/祖细胞分化为红系细胞的诱导培养基及应用 |
CN110093313B (zh) * | 2018-01-29 | 2023-04-14 | 华南生物医药研究院 | 促进造血干/祖细胞分化为红系细胞的诱导培养基及应用 |
Also Published As
Publication number | Publication date |
---|---|
KR20140063861A (ko) | 2014-05-27 |
JP2014527820A (ja) | 2014-10-23 |
US9518250B2 (en) | 2016-12-13 |
EP2748309A4 (en) | 2015-03-11 |
JP6112462B2 (ja) | 2017-04-12 |
SG11201400851PA (en) | 2014-04-28 |
WO2013040644A1 (en) | 2013-03-28 |
EP2748309A1 (en) | 2014-07-02 |
CA2885665A1 (en) | 2013-03-28 |
AU2012313347A1 (en) | 2014-05-08 |
US20140286915A1 (en) | 2014-09-25 |
IL231668A0 (en) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Danet et al. | Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion | |
Phinney et al. | Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at US academic centers | |
ES2856825T3 (es) | Generación de células NK y progenitores de células NK | |
KR100908481B1 (ko) | 중간엽 줄기세포 배양 배지 및 이를 이용한 중간엽줄기세포의 배양 방법 | |
Roy et al. | Hypoxia improves expansion potential of human cord blood–derived hematopoietic stem cells and marrow repopulation efficiency | |
Zhao et al. | Hypoxia with Wharton’s jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells | |
CN101331225B (zh) | 来自脐带血的具有Oct4表达能力的多能成体干细胞及其制备方法 | |
CN102367435B (zh) | 人富血小板血浆的制备及在人间充质干细胞分离培养中的应用 | |
Andrade et al. | Initial CD34+ cell‐enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion | |
Jenhani et al. | Human cytokine expression profile in various conditioned media for in vitro expansion bone marrow and umbilical cord blood immunophenotyped mesenchymal stem cells | |
CN104114694A (zh) | 用于体外扩增造血干细胞和祖细胞的方法 | |
JP2011501960A (ja) | 月経血幹細胞と共に臍帯血由来細胞を共培養する方法 | |
CN107864627A (zh) | 包含粘附基质细胞的方法和组合物 | |
EP1743024B1 (en) | Method of expanding cord blood cells | |
Pranke et al. | Immunophenotype of hematopoietic stem cells from placental/umbilical cord blood after culture | |
Ong et al. | Cotransplantation of Ex Vivo Expanded and Unexpanded Cord Blood Units in Immunodeficient Mice Using Insulin Growth Factor Binding Protein-2–Augmented Mesenchymal Cell Cocultures | |
US20060084170A1 (en) | Cytokine-free growth and maintenance of progenitor cells | |
Gunetti et al. | Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions | |
KR101447902B1 (ko) | 적혈구계 세포의 인 비트로 확장방법 | |
KR20220063446A (ko) | 말초혈액 단핵세포로부터 자연살해세포로의 분화과정 중 분화 또는 증식을 증진시키는 방법 | |
CN1926234B (zh) | 使用nm23的细胞培养,包含nm23的细胞培养基和在nm23存在下培养的细胞的治疗性用途 | |
Srivastava et al. | Comparative engraftment and clonality of macaque HSPCs expanded on human umbilical vein endothelial cells versus non-expanded cells | |
JP2008237136A (ja) | ヒト造血細胞の培養方法 | |
Vulcano et al. | Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice | |
KR20130055313A (ko) | 고밀도 배양을 이용한 적혈구계 세포의 인 비트로 확장방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Floor 9, Queen Street, Melbourne,, Australia Applicant after: Nokhla therapeutics Australia Pty Ltd. Address before: Floor 9, Queen Street, Melbourne,, Australia Applicant before: Cytoplasmic matrix therapeutics Australia Pty Ltd. Address after: Vitoria, Australia Applicant after: Cytoplasmic matrix Co.,Ltd. Address before: Vitoria, Australia Applicant before: CYTOMATRIX Pty Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170213 Address after: Floor 9, Queen Street, Melbourne,, Australia Applicant after: Cytoplasmic matrix therapeutics Australia Pty Ltd. Address before: Vitoria, Australia Applicant before: Cytoplasmic matrix Co.,Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141022 |